Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.52 USD | +5.04% | +3.56% | +46.81% |
Apr. 15 | CorMedix's DefenCath Now Commercially Available For US Inpatient Use | MT |
Apr. 15 | CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin) | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+46.81% | 289M | |
+12.87% | 9B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+20.51% | 2.45B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+3.94% | 1.65B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix to Supply to DefenCath to Florida-based Dialysis Organization